These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 28806663)

  • 1. Management of breast ductal carcinoma in situ in Catalonia, Spain: Results from the Grup Oncologic Calalà-Occità-Catalonia survey with 9-year follow up.
    Cambra MJ; Farrús B; Moreno F; Anglada L; Arenas M; Ballester R; Casals J; Cusidó M; García V; Gutiérrez C; Mollà M; Pedro A; Reyes V; Sanz X
    Breast; 2017 Oct; 35():196-202. PubMed ID: 28806663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patterns of care for ductal carcinoma in situ of the breast: Queensland's experience over a decade.
    Barbour S; Moore J; Dunn N; Effeney R; Harden H; McCarthy A; Walpole E; Lehman M
    Breast; 2017 Oct; 35():169-176. PubMed ID: 28756338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management and 5-year outcomes in 9938 women with screen-detected ductal carcinoma in situ: the UK Sloane Project.
    Thompson AM; Clements K; Cheung S; Pinder SE; Lawrence G; Sawyer E; Kearins O; Ball GR; Tomlinson I; Hanby A; Thomas JSJ; Maxwell AJ; Wallis MG; Dodwell DJ;
    Eur J Cancer; 2018 Sep; 101():210-219. PubMed ID: 30092498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index: a retrospective review with long term follow up.
    Di Saverio S; Catena F; Santini D; Ansaloni L; Fogacci T; Mignani S; Leone A; Gazzotti F; Gagliardi S; De Cataldis A; Taffurelli M
    Breast Cancer Res Treat; 2008 Jun; 109(3):405-16. PubMed ID: 17687650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The management of ductal carcinoma in situ (DCIS). The Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer. Canadian Association of Radiation Oncologists.
    CMAJ; 1998 Feb; 158 Suppl 3():S27-34. PubMed ID: 9484276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trade-offs between survival and breast preservation for three initial treatments of ductal carcinoma-in-situ of the breast.
    Hillner BE; Desch CE; Carlson RW; Smith TJ; Esserman L; Bear HD
    J Clin Oncol; 1996 Jan; 14(1):70-7. PubMed ID: 8558224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Ductal carcinoma in situ of the breast (DCIS). Histopathological features and treatment modalities: analysis of 1,289 cases].
    Cutuli B; Lemanski C; Fourquet A; de Lafontan B; Giard S; Lancrenon S; Meunier A; Pioud-Martigny R; Campana F; Marsiglia H; Mery E; Penault-Llorca F; Fondrinier E; de Lara CT
    Bull Cancer; 2010 Mar; 97(3):301-10. PubMed ID: 20159677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of and treatment for ductal carcinoma in situ of the breast.
    Ernster VL; Barclay J; Kerlikowske K; Grady D; Henderson C
    JAMA; 1996 Mar; 275(12):913-8. PubMed ID: 8598618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Margin width and local recurrence after breast conserving surgery for ductal carcinoma in situ.
    Ekatah GE; Turnbull AK; Arthur LM; Thomas J; Dodds C; Dixon JM
    Eur J Surg Oncol; 2017 Nov; 43(11):2029-2035. PubMed ID: 28917445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Breast ductal carcinoma in situ with microinvasion: pathological review and clinical implications].
    Modesto A; Gandy C; Mery E; Filleron T; Massabeau C; Izar F; Charitansky H; Roché H; de Lafontan B
    Cancer Radiother; 2014 Mar; 18(2):107-10. PubMed ID: 24637020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mammographic features of local recurrence in women who have undergone breast-conserving therapy for ductal carcinoma in situ.
    Liberman L; Van Zee KJ; Dershaw DD; Morris EA; Abramson AF; Samli B
    AJR Am J Roentgenol; 1997 Feb; 168(2):489-93. PubMed ID: 9016233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of ipsilateral breast tumor recurrence after breast-conserving surgery between ductal carcinoma in situ and invasive breast cancer.
    Choi YJ; Shin YD; Song YJ
    World J Surg Oncol; 2016 Apr; 14():126. PubMed ID: 27122132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A review of the management of ductal carcinoma in situ following breast conserving surgery.
    Boxer MM; Delaney GP; Chua BH
    Breast; 2013 Dec; 22(6):1019-25. PubMed ID: 24070852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Retrospective analysis of 108 ductal carcinomas in situ of the breast treated by radiosurgery association].
    Fourneret P; Artignan X; De Cornulier J; Pasquier D; Panh MH; Payan R; Kolodié H; Vincent F; Fric D; Bernard P; Colona M; Bolla M
    Cancer Radiother; 2006 Dec; 10(8):550-8. PubMed ID: 16890006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of concurrent proliferative high-risk lesions on the risk of ipsilateral breast carcinoma recurrence and contralateral breast carcinoma development in patients with ductal carcinoma in situ treated with breast-conserving therapy.
    Adepoju LJ; Symmans WF; Babiera GV; Singletary SE; Arun B; Sneige N; Pusztai L; Buchholz TA; Sahin A; Hunt KK; Meric-Bernstam F; Ross MI; Ames FC; Kuerer HM
    Cancer; 2006 Jan; 106(1):42-50. PubMed ID: 16333852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast-conserving surgery followed by whole-breast irradiation offers survival benefits over mastectomy without irradiation.
    de Boniface J; Frisell J; Bergkvist L; Andersson Y
    Br J Surg; 2018 Nov; 105(12):1607-1614. PubMed ID: 29926900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of local treatment on the recurrence rate of ductal carcinoma in situ.
    Warneke J; Grossklaus D; Davis J; Stea B; Bebb G; Taylor C; Hastings R; Villar H
    J Am Coll Surg; 1995 Jun; 180(6):683-8. PubMed ID: 7773481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term outcome after breast-conservation treatment with radiation for mammographically detected ductal carcinoma in situ of the breast.
    Solin LJ; Fourquet A; Vicini FA; Taylor M; Olivotto IA; Haffty B; Strom EA; Pierce LJ; Marks LB; Bartelink H; McNeese MD; Jhingran A; Wai E; Bijker N; Campana F; Hwang WT
    Cancer; 2005 Mar; 103(6):1137-46. PubMed ID: 15674853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Time trends and inter-hospital variation in treatment and axillary staging of patients with ductal carcinoma in situ of the breast in the era of screening in Southern Netherlands.
    van Steenbergen LN; Voogd AC; Roukema JA; Louwman WJ; Duijm LE; Coebergh JW; van de Poll-Franse LV
    Breast; 2014 Feb; 23(1):63-8. PubMed ID: 24291376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Local recurrence after ductal carcinoma in situ breast conserving treatment. Analysis of 195 cases.
    Cutuli B; Lemanski C; Le Blanc-Onfroy M; de Lafontan B; Cohen-Solal-Le-Nir C; Fondrinier E; Mignotte H; Giard S; Charra-Brunaud C; Auvray H; Gonzague-Casabianca L; Quétin P; Fay R
    Cancer Radiother; 2013 Jun; 17(3):196-201. PubMed ID: 23538041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.